What's New on the FDA Drugs Site
June 12, 2012
- Drug Firm Annual Registration Status Download File
- Drug Firm Annual Registration Status (updated)
- Paragraph IV Patent Certifications (updated)
- Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS): One new report (January to March 2012) and eight updated reports (updated)
June 11, 2012
- The Adverse Event Reporting System (AERS): Latest Quarterly Data Files
- Drug Firm Annual Registration Status Download File
- Drug Firm Annual Registration Status (updated)
- FDA approves Perjeta (pertuzumab) for type of late-stage breast cancer
- National Drug Code Directory (updated)
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
